Rockefeller Financial Services’s Dr. Reddy's Laboratories RDY Stock Holding History

Rockefeller Financial Services’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-6,645	Closed	-$56K	–	536
2017 Q2	$56K	Hold	6,645	–	–	﹤0.01%	376
2017 Q1	$53K	Sell	6,645 -1,595	-19%	-$13.8K	﹤0.01%	394
2016 Q4	$75K	Hold	8,240	–	–	﹤0.01%	396
2016 Q3	$77K	Hold	8,240	–	–	﹤0.01%	368
2016 Q2	$84K	Hold	8,240	–	–	﹤0.01%	369
2016 Q1	$74K	Hold	8,240	–	–	﹤0.01%	386
2015 Q4	$76K	Hold	8,240	–	–	﹤0.01%	406
2015 Q3	$105K	Hold	8,240	–	–	﹤0.01%	376
2015 Q2	$91K	Hold	8,240	–	–	﹤0.01%	370
2015 Q1	$94K	Hold	8,240	–	–	﹤0.01%	385
2014 Q4	$83K	Sell	8,240 -1,255	-13%	-$13.2K	﹤0.01%	367
2014 Q3	$100K	Sell	9,495 -10,385	-52%	-$97.6K	﹤0.01%	364
2014 Q2	$172K	Hold	19,880	–	–	﹤0.01%	349
2014 Q1	$175K	Sell	19,880 -2,410	-11%	-$21K	﹤0.01%	356
2013 Q4	$183K	Buy	22,290 +5,370	+32%	+$42.5K	﹤0.01%	353
2013 Q3	$128K	Hold	16,920	–	–	﹤0.01%	366
2013 Q2	$128K	Buy	+16,920	New	+$124K	﹤0.01%	367

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rockefeller Financial Services's RDY Position: Q3 2017 in Review

Rockefeller Financial Services sold out of Dr. Reddy's Laboratories (RDY) in Q3 2017, closing a stake of 6,645 shares — an estimated $56K sold.

Rockefeller Financial Services first reported a position in RDY in Q2 2013 and held it in 17 quarters. The position peaked at $183K in Q4 2013. 118 funds tracked by Wall St. Rank hold RDY as of Q3 2017.

Rockefeller Financial Services reported no remaining Dr. Reddy's Laboratories position as of Q3 2017 after selling out during the quarter.
Rockefeller Financial Services sold 6,645 Dr. Reddy's Laboratories shares in Q3 2017, an estimated $56K.
Rockefeller Financial Services first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 17 quarters.
Rockefeller Financial Services's Dr. Reddy's Laboratories position peaked at $183K in Q4 2013.
118 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2017.

Based on Rockefeller Financial Services's 13F filing for Q3 2017, filed 20 Oct 2017.